Neuropathology and Brain Imaging – How Can They Inform Each Other ?

I will discuss how brain imaging can be used to build on neuropathological evidence for the potential neural substrates of autism spectrum disorders.
In particular I will present work which builds on prior findings from post mortem and peripheral biomarker studies;  and which is starting to elucidate the potential role(s) of serotonin and glutamate/GABA. The main imaging technologies presented will be DT-MRI, sMRI, and fMRI.